Cargando…
Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion
PURPOSE: To investigate the long-time outcome of patients with branch vein occlusion (BRVO) and central vein occlusion (CRVO) treated with anti-VEGF injections compared to the dexamethasone (DEX) implant. METHODS: This retrospective real-life study included all 492 patients presenting with retinal v...
Autores principales: | de Salles, Manuel Casselholm, Epstein, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380569/ https://www.ncbi.nlm.nih.gov/pubmed/33738625 http://dx.doi.org/10.1007/s00417-021-05146-8 |
Ejemplares similares
-
Retinal venous pressure is decreased after anti-VEGF therapy in patients with retinal vein occlusion–related macular edema
por: Kida, Teruyo, et al.
Publicado: (2021) -
Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France
por: Korobelnik, Jean-François, et al.
Publicado: (2016) -
Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study
por: Li, Xiaoxin, et al.
Publicado: (2017) -
Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial
por: Eter, Nicole, et al.
Publicado: (2016) -
The usefulness of the retinal sensitivity measurement with a microperimetry for predicting the visual prognosis of branch retinal vein occlusion with macular edema
por: Fujino, Ryosuke, et al.
Publicado: (2020)